首页> 美国卫生研究院文献>Experimental and Therapeutic Medicine >Hpyerglycemic and anti-diabetic nephritis activities of polysaccharides separated from Auricularia auricular in diet-streptozotocin-induced diabetic rats
【2h】

Hpyerglycemic and anti-diabetic nephritis activities of polysaccharides separated from Auricularia auricular in diet-streptozotocin-induced diabetic rats

机译:饮食-链脲佐菌素诱导的糖尿病大鼠耳廓多糖分离的血糖和抗糖尿病肾炎活性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Due to substantial morbidity and complications including nephropathy, a search for alternative treatment of diabetes mellitus is urgently required. The present study aimed to investigate the hypoglycemic and anti-diabetic nephropathy activities of polysaccharides separated from Auricularia auricular (AAP). Diet streptozotocin (STZ)-induced diabetic Sprague-Dawley rats were orally treated with metformin (100 mg/kg; positive control) and AAP (100 and 400 mg/kg) for four weeks, and parameters in the serum and liver associated with blood glucose, free radicals and nephropathy were determined. Similar to metformin, AAP treatment strongly reduced blood glucose levels by promoting glucose metabolism. The anti-oxidative activity of AAP, which was indicated by the modulation of superoxide dismutase, glutathione peroxidase, reactive oxygen species and methane dicarboxylic aldehyde levels in serum, was observed in diabetic rats. Furthermore, the regulatory effects of AAP on blood urea nitrogen, creatinine, uric protein and inflammatory-related factors revealed its protection against diabetic nephropathy. The present data suggests that AAP-mediated anti-diabetic and anti-nephritic effects are partially associated with their modulations on the anti-oxidative system and nuclear factor kappa B-related signaling pathway. In conclusion, AAP has potential to be a novel source of treatments for diabetes.
机译:由于大量的发病率和包括肾病在内的并发症,迫切需要寻找糖尿病的替代治疗方法。本研究的目的是调查耳廓多糖(AAP)分离多糖的降血糖和抗糖尿病肾病活性。日粮链脲佐菌素(STZ)诱导的糖尿病Sprague-Dawley大鼠口服二甲双胍(100 mg / kg;阳性对照)和AAP(100和400 mg / kg)口服治疗四周,血清和肝脏中与血液相关的参数测定葡萄糖,自由基和肾病。与二甲双胍相似,AAP治疗可通过促进葡萄糖代谢来大大降低血糖水平。在糖尿病大鼠中观察到AAP的抗氧化活性,其通过调节血清中的超氧化物歧化酶,谷胱甘肽过氧化物酶,活性氧和甲烷二羧酸醛水平来表明。此外,AAP对血尿素氮,肌酐,尿酸蛋白和炎性相关因子的调节作用揭示了它对糖尿病性肾病的保护作用。目前的数据表明,AAP介导的抗糖尿病和抗肾病作用与其在抗氧化系统和核因子κB相关信号传导途径上的调节部分相关。总之,AAP有望成为糖尿病治疗的新来源。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号